Efficacy, Safety, and Pharmacokinetics of Candesartan Cilexetil in Hypertensive Children Aged 6 to 17 Years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy, Safety, and Pharmacokinetics of Candesartan Cilexetil in Hypertensive Children Aged 6 to 17 Years

Published:2008-10 Issue:10 Volume:10 Page:743-750
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:

Author:

Trachtman Howard,Hainer James W.,Sugg Jennifer,Teng Renli,Sorof Jonathan M.,Radcliffe Jerilynn,

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference29 articles.

1. Overweight, ethnicity, and the prevalence of hypertension in school-aged children;Sorof;Pediatrics,2004

2. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association;Hanevold;Pediatrics,2004

3. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension;Daniels;Circulation,1998

4. Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension;Brady;J Pediatr,2008

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Angiotensin Receptor Blockers in Pediatric Patients (Aged 6 to 18) with Hypertension: A Systematic Review;IRAN J KIDNEY DIS;2023

2. Progression of Chronic Kidney Disease and Nephroprotective Therapy;Pediatric Kidney Disease;2023

3. Changes in Drug Development Regulations and Their Impact on Clinical Trials;Pediatric Hypertension;2023

4. Pharmacologic Treatment of Pediatric Hypertension;Pediatric Hypertension;2023

5. Narrative update of clinical trials with antihypertensive drugs in children and adolescents;Frontiers in Cardiovascular Medicine;2022-11-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3